Literature DB >> 7645427

Role of apoptosis in the growth inhibitory effects of vitamin D in MCF-7 cells.

J Welsh1, M Simboli-Campbell, C J Narvaez, M Tenniswood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7645427     DOI： 10.1007/978-1-4899-0949-7_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  9 in total

1.  Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling.

Authors:  Pamela A Marshall; Zachary Hernandez; Ichiro Kaneko; Tim Widener; Christa Tabacaru; Izayadeth Aguayo; Peter W Jurutka
Journal:  J Steroid Biochem Mol Biol       Date:  2012-05-14       Impact factor: 4.292

2.  Identification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells.

Authors:  Belinda Byrne; JoEllen Welsh
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-24       Impact factor: 4.292

Review 3.  Vitamin D and differentiation in cancer.

Authors:  Elzbieta Gocek; George P Studzinski
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

4.  Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines.

Authors:  Rebecca L Hillyer; Padma Sirinvasin; Madhura Joglekar; Robert A Sikes; Kenneth L van Golen; Anja Nohe
Journal:  Clin Exp Metastasis       Date:  2012-05-20       Impact factor: 5.150

5.  Vitamin D transport proteins megalin and disabled-2 are expressed in prostate and colon epithelial cells and are induced and activated by all-trans-retinoic acid.

Authors:  Shantel B Ternes; Matthew J Rowling
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

6.  Dissociation of vitamin D3 and anti-estrogen mediated growth regulation in MCF-7 breast cancer cells.

Authors:  E Nolan; M Donepudi; K VanWeelden; L Flanagan; J Welsh
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

7.  Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells.

Authors:  Timothy M Chlon; David A Taffany; Joellen Welsh; Matthew J Rowling
Journal:  J Nutr       Date:  2008-07       Impact factor: 4.798

8.  Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies.

Authors:  Robert Wieder; Steven C Novick; Bruce W Hollis; Margarette Bryan; Suzanne M Chanel; Kate Owusu; Danielle Camastra; Tracie Saunders; Lillian Pliner; Jonathan Harrison; Peter Bonate; Tom Williams; Steven Soignet
Journal:  Invest New Drugs       Date:  2003-11       Impact factor: 3.850

9.  1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells.

Authors:  N Dunlap; G G Schwartz; D Eads; S D Cramer; A B Sherk; V John; C Koumenis
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.